baber/WOPTO huggingface dataset:
Patent CA-2571428-C (CA)
Title: Custom mouthguard
Inventor: AMBIS EDWARD J JR
IPC: A63B71/08
Filed: 2005-06-23
Granted: 2013-04-02
Abstract: A custom mouthguard has a resilient U-shaped body with an anterior wall and a posterior wall. A post dam on the posterior wall forms a seal with palatal tissue to increase retention of the mouthguard in a waver~s mouth. The increased retention allows a wearer to speak and open mouth breath while wearing the mouthguard. The mouth guard also has an indexed region that serves to mutually stabilize maxillary teeth, mandibular teeth, mandible and TMJ  components. Mouthguard methods and processes are also disclosed.
Patent CA-2572778-C (CA)
Title: Box for bag-in box package with spout location assist port
Inventor: BIUNDO VITO
IPC: B65D5/70
Filed: 2007-01-03
Granted: 2012-03-06
Abstract: A box for receiving a bag having a spout may comprise a first member comprising a spout access tab and a second member comprising a spout location assist tab spaced apart from the spout access tab. Alternatively, a box may comprise a tray comprising a first removable portion, a lid adaptable to be fastened to the tray, the lid comprising a second removable portion, at least one of the tray and the lid comprising a third removable portion, wherein the first, second, and third removable portions may be removed to form a combined spout access port and spout location assist port. Other alternative embodiments and methods are also disclosed.
Patent CA-2574896-C (CA)
Title: (1s,5s)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane benzenesulfonate
Inventor: WAYNE GREG S
IPC: C07D487/04
Filed: 2005-07-08
Granted: 2012-01-03
Abstract: The present invention relates to the salt (1S,5S)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane benzenesulfonate and to methods of preparing the salt.
Patent CA-2576049-C (CA)
Title: Methods for providing neuroprotection for the animal central nervous system against the effects of ischemia, neurodegeneration, trauma, and metal poisoning
Inventor: FREY WILLIAM H II
IPC: A61K31/165
Filed: 2005-08-11
Granted: 2013-11-05
Abstract: Methods for preconditioning and/or providing neuroprotection to the animal brain against cerebral ischemic and neurodegenerative effects, including cognitive, behavioral and physical impairments that often accompany Methods and pharmaceutical compositions for preconditioning and/or providing neuroprotection to the animal central nervous system against the effects of ischemia, trauma, metal poisoning and neurodegeneration, including the associated cognitive, behavioral and physical impairments. In one embodiment, the method is accomplished by stimulating and stabilizing hypoxia-inducible factor-1.alpha. (HIF-1.alpha.). HIF-1.alpha. is known to provide a neuroprotective benefit under ischemic conditions. Patients at risk for certain diseases or disorders that are associated with risk for cerebral ischemia may benefit, e.g., those at risk for Alzheimer's disease, Parkinson's disease, Wilson's disease or stroke or those patients having head or spinal cord injury. Patients undergoing certain medical procedures that may result in ischemia may also benefit. Initially, the possibility of ischemia or neurodegeneration is recognized. Intranasal therapeutic agents are administered to the upper third of the nasal cavity to bypass the blood-brain barrier and access the central nervous system directly to avoid unwanted and potentially lethal side effects. Therapeutic agents include those substances that interact with iron and/or copper such as iron chelators, copper chelators, and antioxidants. A particular example of such therapeutic agents is the iron chelator deferoxamine (DFO). Intranasal administration of DFO is known to stimulate and/or stabilize HIF-1.alpha. and provides an efficient and safe method for pre-conditioning the brain to protect against cerebral ischemia. Moreover, DFO is shown to decrease weight loss in subjects when administered pre and/or post stroke.
Patent CA-2576473-C (CA)
Inventor: MATSUMOTO MASARU
IPC: A61K9/08
Filed: 2005-08-24
Granted: 2015-06-30
Abstract: An effective liquid preparation achieves high bioavailability (BA) of physiologically active peptides or proteins, including ghrelins, that are administered as drugs. Also provided is a method for improving the BA of physiologically active peptides or proteins, including ghrelins, that are subcutaneously injected in aqueous solutions. The liquid preparation contains: a physiologically active peptide or protein, such as ghrelins, as an active ingredient; an acid solution including one or a combination of two or more selected form the group consisting of acetic acid, lactic acid, phosphoric acid, glycine, citric acid, hydrochloric acid, propionic acid, butyric acid, benzoic acid and salts thereof; an alcohol; and a polar organic liquid including one or a combination of two or more selected from the group consisting of N-methyl-2-pyrrolidone, dimethylformamide, dimethylsulfoxide and methylparaben.
Patent CA-2579257-C (CA)
Inventor: NEUMAN GEORGE
IPC: B32B15/00
Filed: 2005-09-02
Granted: 2011-01-25
Abstract: A coated article is provided with a low-emissivity (low-E) layer stack for use in a window unit or the like. The layer stack, or coating, may permit the coated article to achieve one or more of a low solar factor (SF) value, a high selectivity (Tvis /SF) value, substantially neutral color at normal and/or off-axis viewing angles, and/or low emissivity. When high selectivity values are achieved, there is provided a high ratio of visible transmission to SF, which is a desirable feature in certain example instances. In certain example embodiments, asymmetric IR reflecting layer thicknesses may be used (e.g., bottom IR reflecting layer thicker than the top IR reflecting layer), and/or different contact layers for the top/bottom IR reflecting layers may be used to help achieve a combination of low SF values, high selectivity, and good coloration at normal and/or off-axis viewing angles.
Patent CA-2580209-C (CA)
Title: Dispositif de protection embolique a film mince a memoire de forme
Inventor: DINH MINH Q
IPC: A61F2/01
Filed: 2005-09-15
Granted: 2013-11-12
Abstract: L'invention porte sur un filtre vasculaire amovible permettant la capture et l'extraction d'un embole pendant le déroulement continu d'une perfusion sanguine. Ce système est utile pour toute angioplastie percutanée, pose de stent, thrombolyse ou ablation de tissue. Le système peut minimiser l'incidence d'une attaque, d'un infarctus du myocarde ou d'autres complications cliniques que l'on peut associer à de telles procédures.
Patent CA-2586079-C (CA)
Title: Can end
Inventor: FIELDS BRIAN
IPC: B65D8/20
Filed: 2005-11-01
Granted: 2014-05-27
Abstract: A can end having a countersink bead (35), an inclined chuck wall (38) and a strong seam, resists distortion from its circular profile when subjected to thermal processing or when packaging carbonated beverages. The can end of the invention has control features introduced which control the failure mode whilst maintaining specified buckle pressure performance. In one embodiment, the can end has a two part wall (42, 44) and a control feature that comprises expansion (50) of the countersink bead to act as a trigger for local peaking, together with a groove in the chuck wall which prevents the peaking force from being concentrated at a single point which could result in leaking by the production of a pin hole.
Patent CA-2597593-C (CA)
Title: Integrated fec decoding and iterative diversity reception
Inventor: MILLER MARK
IPC: H04L1/02
Filed: 2006-02-14
Granted: 2010-07-27
Abstract: Methods, apparatuses, and systems are presented for deriving data from an error correction encoded composite signal involving (a) receiving a composite signal comprising contributions from a plurality of individual signals transmitted over different paths representing a common data sequence encoded using an error correction code, (b) calculating soft values of a first type taking into account the received composite signal and soft values of a second type, (c) generating symbol outputs taking into account soft values of the first type, (d) performing error correction decoding on the symbol soft outputs, (e) calculating soft values of the second type taking into account error correction decoded outputs , (f) feeding back soft values of the second type, (g) iteratively updating soft values of the first type, symbol outputs, error correction decoded outputs, and soft values of the second type by repeating previous steps, and (h) providing updated error correction decoded outputs.
Patent CA-2597749-C (CA)
Inventor: ESTEVE VICTOR
IPC: B65D1/02
Filed: 2005-09-29
Granted: 2013-06-04
Abstract: Constructive disposition applied in medical drugs and cosmetic items packaging, or more particularly, the present Utility Model presents constructive and functional enhancements, specially developed for the utilization of the whole medical drugs or cosmetic items content, and for such, it is formed by two pieces, being one container (1) and one base (2), such as the container (1) presents a conformation practically cylindrical and its bottom presents a conic shape (3), in 'V', enabling the utilization of the total added content and the perfect dosing capitation.
Patent CA-2597755-C (CA)
Title: Gas system for welding-type devices
Inventor: STANZEL KENNETH A
IPC: B23K9/32
Filed: 2006-01-08
Granted: 2010-11-09
Abstract: A welding-type device and gas system for use therewith are disclosed. The gas system of the welding-type device includes a canister that is constructed to contain a shielding gas therein and is connectable to the welding-type device.  The canister is sized to be mounted to the welding- type device when it is attached thereto such that the welding-type device can be efficiently and conveniently transported from one location to another with the source of shielding gas securely affixed thereto.
Patent CA-2601397-C (CA)
Title: Fluid mixer
Inventor: SCHMITT RANDALL PAUL
IPC: G05D23/185
Filed: 2006-04-06
Granted: 2010-11-16
Abstract: A fluid mixer (20) including a mixing element (64) configured to separate and mix hot and cold water streams (66, 68).
Patent CA-2604101-C (CA)
Inventor: HOMMAN MOHAMMED
IPC: G01N15/10
Filed: 2006-02-17
Granted: 2014-01-21
Abstract: A cell (14) is provided that contains a plurality of virus particles (16). A first image (20) of a first virus particle (22) and a second image (32) of a second virus particle (34) are taken by electron microscopy technology. The first virus particle is characterized as being in a first maturity stage and the second virus particle as being in a second maturity stage. The first image (20) and the second image (32) are transformed to first and second gray scale profiles (24, 46), respectively, based on pixel data. The first and second gray scale profiles (24, 36) are then saved as first and second templates, respectively. A third virus particle in a third image is identified. The third image is transformed into a third gray scale profile. The third gray scale is compared to the first and second template to determine a maturity stage of the third virus particle.
Patent CA-2604835-C (CA)
Inventor: STOJANOVIC MARKO
IPC: A61K35/745
Filed: 2006-04-04
Granted: 2014-12-30
Abstract: Disclosed herein are compositions that may be sufficiently stable such that probiotic microorganisms are present in the compositions at the time of ingestion by a mammal. The compositions comprise: (a) a probiotic component; and (b) a sweetener component; wherein the composition is substantially free of a chewing gum base. Further disclosed are methods of prophylactic, therapeutic treatment or non-therapeutic treatment to alleviate diseases or conditions, or enhance overall health, that affect a mammal comprising administration of a composition as described herein.
Patent CA-2606401-C (CA)
Inventor: NEWBERG IRWIN L
IPC: H01Q21/00
Filed: 2006-08-28
Granted: 2013-08-06
Abstract: Provided is an antenna transceiver system (100) for transmitting, receiving and processing voice, digital data, radar and IR signals. The system (100) includes an antenna array (102) having a plurality of radiating elements (110, 112, 114), each element (110, 112, 114) connected to a transmit/receive ("T/R") module (104, 106, 108). Each T/R module (104, 106, 108) may include phase shifters (200, 202, 204) and a phase conjugation module (206, 208, 210) for transmitting a return signal along a beam path of an incoming signal. The system (100) is disposed on a plurality of vertically aligned planes (402) integrated into a compact tile (400). The tiles (400) can be embedded in a headgear (500) of a user, allowing for hands-free operation of the system.  Alternatively, the system (100) can be integrated into a vehicle (700), man-transportable backpack (800), or other designated platforms.
Patent CA-2607604-C (CA)
Title: Process for preparing alkyl(meth)acrylates from alkyl .alpha.-hydroxycarboxylates
Inventor: ACKERMANN JOCHEN
IPC: C07C67/327
Filed: 2006-05-12
Granted: 2012-01-03
Abstract: The present invention relates to processes for preparing alkyl (meth)acrylates, comprising the steps of transesterifying an alkyl .alpha.-hydroxycarboxylate with (meth)acrylic acid to obtain alkyl (meth)acrylates and .alpha.-hydroxycarboxylic acid, and dehydrating the .alpha.-hydroxycarboxylic acid to obtain (meth)acrylic acid.
Patent CA-2608558-C (CA)
Title: Phase ambiguity resolution method for a satellite-based positioning system
Inventor: EULER HANS-JUERGEN
IPC: G01S19/44
Filed: 2006-05-16
Granted: 2014-10-14
Abstract: The invention relates to a satellite-based positioning system in which a transmitter (2) emits electromagnetic radiation at least at N >= 3 carrier frequencies (3, 4, 5). In order to resolve the phase ambiguity for said satellite-based positioning system, the electromagnetic radiation is received by a receiver (1), and K pseudo paths (3a, 4a, 5a, 6a) and L carrier phases (3b, 4b, 5b, 6b), especially at least two pseudo paths (3a, 5a) and at least two carrier phases (3b, 4b), are derived from the received radiation as M  pieces of distance data, wherein M = K + L. In order to determine the position, the integer phase ambiguity is derived from the linear combination of a maximum of M <= 2N-1 pieces of distance data.
Patent CA-2615393-C (CA)
Inventor: BAGCHI INDRANI C
IPC: A61K38/00
Filed: 2006-07-19
Granted: 2011-09-20
Abstract: Disclosed are methods and compositions containing endothelin receptor antagonists for emergency contraception.
Patent CA-2618048-C (CA)
Title: Two-piece can, method for manufacturing same, and steel sheet therefor
Inventor: KOJIMA KATSUMI
IPC: B65D1/00
Filed: 2006-08-10
Granted: 2010-12-07
Abstract: The object is to obtain a two-piece can which has sufficient can strength and excellent corrosion resistance and to provide a method for forming the two-piece can easily without generating cracks. The means to achieve the object is to manufacture the two-piece can by the method using a laminated steel sheet as the base material, having the steps of: drawing a cylindrical blank for several times to form a can body in a shape of cylinder integrated with bottom; forming a tapered part extending outward from the can body in the radial direction thereof at the tip of the opening of the can body; applying diametral reduction to the tapered part to the diameter of the can body; and applying diametral reduction to the opening side of the can body to a diameter smaller than the diameter of the can body, while satisfying the formulae (1) and (2). The two-piece can is obtained further by forming a dome protruding inside of the can at the can bottom, by trimming the opening of the can body, by applying diametral reduction to the opening of the can body, after the trimming, to a diameter smaller than the diameter of the can body, while satisfying the formulae (1) and (2), by forming a bead, after the diametral reduction, at the opening end of the can body, by heating the can to a temperature ranging from the glass transition point of the film of the laminated steel sheet to the melting point thereof + 30°C in the stage of the degree of working in a range of 0.2 <= d/R <= 0.5 and of 1.5 <= h/(R - r) <= 2.5, then by applying heat treatment giving rapid cooling to a temperature at or below the glass transition point within 30 seconds. 1.5 <= h/(R - r) (1) d/R <= 0.25 (2) where, h is the height from the can bottom to the tip of the opening, R is the circular blank positional radius, r is the radius of the can bottom, and d is the radius of the tip of the opening.
Patent CA-2619397-C (CA)
Title: Systeme et methode pour autoriser l'acces a un service de telecommunications sans fil sur reseau ip
Inventor: CALDWELL CHRISTOPHER E
IPC: H04L9/32
Filed: 2007-10-22
Granted: 2015-03-31
Abstract: L'invention concerne un système pour fournir un dispositif de télécommunications sans fil basé sur IP à un accès à un service de télécommunications sans fil basé sur IP fourni par un réseau porteur, comprenant un point d'accès qui établit une liaison radio avec le dispositif de télécommunications sans fil basé sur IP, et couple le dispositif de télécommunications sans fil basé sur IP au réseau. Le système comprend également un contrôleur de réseau en communication avec le réseau porteur et le point d'accès. Le contrôleur de réseau est configuré pour recevoir des paquets de données correspondant au dispositif de télécommunications sans fil basé sur IP au niveau du point d'accès. Le contrôleur de réseau est également configuré pour accepter/rejeter la fourniture du service de télécommunications sans fil basé sur IP au dispositif de télécommunications sans fil basé sur IP sur la base d'une adresse IP ou un autre identifiant unique associé au point d'accès. Selon d'autres exemples, le système comprend en outre une mémoire de données qui associe des adresses IP de points d'accès (ou d'autres identifiants) à un indicateur d'un statut de liste noire ou de liste blanche. D'autres dispositifs et systèmes sont également décrits.
Patent CA-2624504-C (CA)
Title: Benzimidazolone compounds which have activity at m1 receptor and their uses in medicine
Inventor: BUDZIK BRIAN
IPC: A61K31/4184
Filed: 2006-09-27
Granted: 2014-07-08
Abstract: Compounds which have activity at M1 receptor and their uses in medicine Compounds of formula (I) and salts and solvates are provided: wherein R4 is fluoro, R5 is selected from hydrogen, halogen, cyano, C1-6alkyl, C1-6alkyl substituted with one or more fluorine atoms, C1-6alkoxy, and C1-6alkoxy substituted with one or more fluorine atoms; and R6 is selected from halogen, cyano, C1-6alkyl, C1-6alkyl substituted with one or more fluorine atoms, C3-6cycloalkyl, C3-6cycloalkyl substituted with one or more fluorine atoms, C1-6alkoxy and C1-6alkoxy substituted with one or more fluorine atoms, and Q is hydrogen or C1-6alkyl. The compounds are expected to be useful for therapy, for example in the treatment of psychotic disorders and cognitive impairment.
Patent CA-2625133-C (CA)
Inventor: FISH JASON
IPC: F02C7/22
Filed: 2008-03-10
Granted: 2015-06-02
Abstract: A mounting system for an annular internal fuel manifold disposed within a gas generator case of a gas turbine engine including at least one fastener support assembly and at least one receiving element, each fastener support assembly including a primary fastener engaging the receiving element to constrain a relative movement between the fuel manifold and the gas generator case in an axial direction while allowing the relative movement in a radial direction and a secondary fastener in position to passively and automatically engage the receiving element upon failure of the primary fastener.
Patent CA-2628387-C (CA)
Inventor: HOHLA KRISTIAN
IPC: A61B3/103
Filed: 2000-10-20
Granted: 2013-09-24
Abstract: A system and method are provided in which an iris or eye image is taken during a refractive diagnostic analysis. The image is employed for aligning data from the analysis with data from other refractive analysis instruments, as well as aligning a refractive surgical tool, such as a laser, with the eye for treatment. Further, the stored iris image is compared with the patient's iris before treatment, verifying that the correct eye is to be treated with a developed treatment pattern. A variety of refractive instruments can be used, such as corneal topography systems and wavefront aberration systems.
Patent CA-2633746-C (CA)
Inventor: SUGIYAMA HITOSHI
IPC: E21B43/12
Filed: 2006-12-19
Granted: 2014-04-08
Abstract: A method and system for the produc-tion of a gas hydrate including the steps of drilling into a subterranean gas hydrate formation and at least partially depressurizing the gas hydrate formation to permit separation of gas and water from the hydrate form. The gas and water is then pumped from the for-mation and recovered from the well. At least a portion of water pumped from the well is water that is intro-duced into the well from the surface or reintroduced by a feed back loop from the production operation.
Patent CA-2636671-C (CA)
Inventor: WEIMER THOMAS
IPC: C12N9/64
Filed: 2007-02-03
Granted: 2016-08-30
Abstract: The present invention relates to the fields of Factor VII (FVII) and Factor Vila (FVIIa) albumin linked polypeptides. More specifically, the invention relates to cDNA sequences coding for human Factor VII and Factor Vila and derivatives genetically fused to a cDNA coding for human serum albumin which may be linked by oligonucleotides which code for intervening peptidic linkers such encoded derivatives exhibiting improved stability and extended functional plasma half-life, recombinant expression vectors containing such cDNA  sequences, host cells transformed with such recombinant expression vectors, recombinant polypeptides and derivatives which do have biological activities of the unmodified wild type protein but having improved stability and prolonged shelf-life and processes for the manufacture of such recombinant proteins and their derivatives. The invention also covers a transfer vector for use in human gene therapy, which comprises such modified DNA sequences.
Patent CA-2638781-C (CA)
Title: Sealed containers and methods of making and filling same
Inventor: ASSION NORBERT M
IPC: B65B7/16
Filed: 2003-09-03
Granted: 2010-02-02
Abstract: A medicament vial assembly includes a storage vial (310), a stopper member (330) and a securing ring (350, 370). The storage vial has a body portion (312) which defines an interior chamber (318) for storing a predetermined medicament and a neck portion through which medicament is received into and withdrawn from the interior chamber. The stopper member (330) is inserted into the mouth of the vial and establishes a first seal. The securing ring (350, 370) is engaged with the mouth of the vial and adapted and configured for retaining the stopper member (330) within the vial mouth and effectuating a second seal.
Patent CA-2645492-C (CA)
Title: Systeme desintegrateur pour matieres cellulosiques seches
Inventor: HATA SEIJI
IPC: B02C18/14
Filed: 2007-03-12
Granted: 2016-11-22
Abstract: Selon la présente invention, une biomasse cellulosique est réduite en micropoudre avec des particules ayant des diamètres moyens inférieurs à 5-10 micromètres, une fraction importante des particules ayant des diamètres inférieurs à 1 micromètre. La biomasse (par exemple, bois, déchets agricoles ou autres matières végétales) est d'abord traitée en morceaux ayant un diamètre maximum d'environ 10 mm. Le résultat est ensuite séché pour réduire sa teneur en eau à un maximum d'environ 15 % en masse et placé dans un désintégrateur qui réduit la taille de particule à environ 1 mm. La biomasse est ensuite traitée avec un broyeur à disques, les bords de disques rotatifs se déplaçant le long d'une rainure avec une pression de la biomasse, ce qui broie les morceaux en particules de plus en plus petites. La micropoudre obtenue est très sensible à une hydrolyse enzymatique ou chimique en sucres constituants. En outre, la micropoudre peut être suspendue dans un flux d'air et brûlée directement pour alimenter en chaleur des chaudières et des dispositifs similaires.